Hematology/Pathology Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA advisory panel meeting August 5 in Rockville, Maryland. Open committee discussion will cover a "points-to-consider document for automated cervical cancer slide readers and automated cervical cancer slide preparation instruments"; "home-use prothrombin time tests"; "standardization of coagulation assays and reagents"; "hematology replacement reagents"; and "a briefing on the FDA Immunohistochemical Products Workshop" held June 28-29. The panel will discuss general issues related to prothrombin time tests, not specific premarket approval applications, FDA says. For more information, call Larry Brindza at 301/594-2096